2025
FEBRUARY
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 2
309
COMPREHENSIVE REHABILITATION FOR ALCOHOLISM: RECOVERY AND
TREATMENT APPROACHES
Turayev Bobir Temirpulotovich
Assistant of the department of psychiatry, medical psychology and narcology, Samarkand State
Medical University, Samarkand, Republic of Uzbekistan.
https://doi.org/10.5281/zenodo.14926493
Abstract.
Alcoholism is a long-term, relapsing disorder characterized by an overpowering
and uncontrollable urge to consume alcohol, a diminished ability to regulate drinking behavior,
and the onset of distressing emotional and physical symptoms during withdrawal. This condition
profoundly impacts an individual’s overall well-being, affecting not only their physical health but
also their psychological stability and social functioning.
Keywords:
Comprehensive rehabilitation, alcoholism, treatment approaches, physical
health, psychological stability.
Introduction.
The rehabilitation process is designed to address the complex and
multifaceted nature of alcoholism by implementing a holistic approach that fosters recovery across
multiple domains. Effective rehabilitation programs aim to restore physical health through
medically supervised detoxification, manage psychological distress through therapeutic
interventions, and rebuild social connections by facilitating reintegration into the community. By
combining medical, psychological, and social support strategies, comprehensive rehabilitation
enhances the chances of long-term sobriety, reduces the risk of relapse, and helps individuals
regain control over their lives [1-4].
Alcoholism is a chronic, relapsing disorder that is marked by an uncontrollable compulsion
to consume alcohol, an inability to regulate intake, and the emergence of distressing emotional and
physical symptoms during withdrawal. The rehabilitation process is designed to address the
multifaceted nature of this condition by promoting recovery in physical, psychological, and social
domains. Effective alcoholism rehabilitation involves a comprehensive approach that includes
medical detoxification to safely manage withdrawal symptoms, psychological therapy to address
underlying emotional and behavioral issues, pharmacological interventions to reduce cravings and
prevent relapse, and social reintegration programs aimed at helping individuals rebuild
relationships, regain employment, and reintegrate into society. This article delves into the essential
components of alcoholism rehabilitation, highlighting the importance of a multidisciplinary
approach in fostering long-term recovery and preventing relapse [5-8].
2025
FEBRUARY
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 2
310
This article explores evidence-based approaches to alcoholism rehabilitation, including
cognitive-behavioral therapy (CBT), which helps individuals identify and modify maladaptive
thought patterns and behaviors associated with alcohol use; motivational interviewing (MI), which
enhances an individual’s intrinsic motivation to change by resolving ambivalence toward
recovery; and medication-assisted treatment (MAT), which utilizes pharmacological interventions
to reduce cravings and withdrawal symptoms. Additionally, the significance of support groups,
such as Alcoholics Anonymous (AA) and other peer-based recovery programs, is examined in
fostering a sense of community and accountability. The article also analyzes the importance of
long-term follow-up care, including regular counseling sessions, medical monitoring, and relapse
prevention strategies, in ensuring sustained recovery and minimizing the risk of relapse [9-14].
1. Introduction
Alcohol use disorder (AUD) is a serious public health issue that poses substantial medical,
psychological, and socio-economic challenges. Its consequences extend beyond the individual,
affecting families, communities, and healthcare systems. Effective rehabilitation requires a
comprehensive, multidimensional approach that integrates medical, psychological, and social
interventions tailored to the needs of each patient. The core objectives of rehabilitation include
safe and medically supervised detoxification to manage withdrawal symptoms, long-term
maintenance of abstinence through behavioral and pharmacological strategies, relapse prevention
via structured therapy and support systems, and successful reintegration into society by improving
social functioning, employment opportunities, and overall quality of life [15-19].
2. Medical Detoxification
Detoxification is the crucial initial phase of alcoholism rehabilitation, focusing on the safe
and effective management of withdrawal symptoms that arise when alcohol consumption is
abruptly discontinued. These symptoms can vary in severity, ranging from mild manifestations
such as anxiety, tremors, insomnia, and nausea to more severe and potentially life-threatening
conditions, including seizures and delirium tremens (DTs). To mitigate these risks and ensure
patient safety, pharmacological interventions play a key role. Benzodiazepines, such as diazepam
and lorazepam, are commonly prescribed to reduce withdrawal severity, prevent seizures, and
manage agitation. In addition to medication, comprehensive supportive care is essential during
detoxification. This includes proper hydration, electrolyte balance, and nutritional
supplementation, as chronic alcohol use often leads to vitamin deficiencies, particularly thiamine
(vitamin B1) deficiency, which can result in serious neurological complications such as Wernicke-
Korsakoff syndrome.
2025
FEBRUARY
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 2
311
A well-structured detoxification process, typically conducted under medical supervision,
serves as the foundation for further rehabilitation efforts, enabling patients to transition safely into
long-term treatment programs aimed at achieving sustained recovery [20-27].
3. Psychological Therapy
Behavioral therapies are fundamental to achieving long-term recovery from alcoholism, as
they address the psychological and behavioral aspects of addiction. These therapeutic approaches
help individuals recognize and modify harmful drinking patterns, develop healthier coping
strategies, and build resilience against relapse. Cognitive-Behavioral Therapy (CBT) is one of the
most widely used methods, helping patients identify triggers, challenge negative thought patterns,
and adopt constructive behaviors to manage stress and cravings. Motivational Interviewing (MI)
is another effective technique that enhances an individual’s intrinsic motivation to change by
resolving ambivalence and reinforcing commitment to sobriety. Additionally, Contingency
Management (CM) utilizes positive reinforcement strategies, such as rewards for abstinence, to
encourage sustained recovery. Group therapy and family therapy also play essential roles in
strengthening social support systems, improving communication, and addressing interpersonal
conflicts that may contribute to alcohol use. By integrating these behavioral interventions into a
comprehensive rehabilitation program, individuals are more likely to develop the necessary skills
and mindset for maintaining long-term sobriety and preventing relapse [28-32].
Cognitive-Behavioral Therapy (CBT): CBT helps patients identify and modify
maladaptive thoughts and behaviors related to alcohol use. Cognitive-Behavioral Therapy (CBT)
is a highly effective, evidence-based approach that helps individuals struggling with alcohol use
disorder (AUD) recognize, understand, and change maladaptive thought patterns and behaviors
associated with their drinking. This therapeutic method focuses on identifying triggers that lead to
alcohol consumption, challenging irrational or harmful beliefs about alcohol use, and developing
healthier coping mechanisms to manage cravings and stress. Through structured sessions, patients
learn problem-solving skills, emotion regulation strategies, and techniques to prevent relapse. CBT
empowers individuals by increasing their self-awareness and resilience, ultimately enabling them
to make more positive and sustainable lifestyle choices that support long-term sobriety [33].
Motivational Interviewing (MI): MI enhances an individual's motivation to change by
resolving ambivalence toward quitting alcohol. Motivational Interviewing (MI) is a client-
centered, evidence-based counseling approach designed to enhance an individual's intrinsic
motivation to change by addressing and resolving ambivalence about quitting alcohol.
2025
FEBRUARY
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 2
312
This technique is based on collaboration rather than confrontation, empowering individuals
to explore their own reasons for change in a supportive and non-judgmental environment. MI helps
patients recognize the discrepancies between their current behaviors and long-term goals,
reinforcing their commitment to making healthier choices. Through open-ended questions,
reflective listening, and affirmations, therapists guide individuals toward self-motivated decisions,
ultimately increasing their readiness to reduce or eliminate alcohol consumption and engage in
sustained recovery [34-38].
Contingency Management (CM): CM reinforces abstinence through a reward-based
system. 12-Step Facilitation Therapy: This approach, associated with Alcoholics Anonymous
(AA), fosters peer support and accountability. 12-Step Facilitation Therapy is a structured,
evidence-based approach that encourages individuals struggling with alcohol use disorder to
engage in the principles and practices of Alcoholics Anonymous (AA). This therapy emphasizes
the importance of peer support, personal accountability, and spiritual growth in the recovery
process. By fostering connections with a supportive community, individuals are guided through
the 12 steps, which include admitting powerlessness over alcohol, seeking help from a higher
power or supportive network, making amends for past mistakes, and committing to continuous
self-improvement. The approach helps individuals develop coping strategies, build resilience, and
maintain long-term sobriety through regular participation in AA meetings and peer-led discussions
[39-43].
4. Pharmacological Treatment
Medications can aid in reducing cravings and preventing relapse. Pharmacological
interventions play a crucial role in alcoholism rehabilitation by helping to reduce cravings, manage
withdrawal symptoms, and prevent relapse. Medications such as naltrexone, acamprosate, and
disulfiram are commonly prescribed to support long-term sobriety. Naltrexone works by blocking
the euphoric effects of alcohol, reducing the desire to drink. Acamprosate helps restore the balance
of neurotransmitters in the brain, alleviating post-acute withdrawal symptoms and decreasing the
urge to consume alcohol. Disulfiram acts as a deterrent by causing unpleasant reactions when
alcohol is ingested, reinforcing abstinence. When combined with behavioral therapies and a strong
support system, these medications significantly enhance the chances of sustained recovery and
long-term success in overcoming alcohol dependence [44-48].
Disulfiram: An aversive agent that causes unpleasant reactions when alcohol is consumed.
Disulfiram is a pharmacological agent used in the treatment of alcohol dependence.
2025
FEBRUARY
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 2
313
It functions as an aversive therapy by inhibiting the enzyme acetaldehyde dehydrogenase,
leading to the accumulation of acetaldehyde in the div when alcohol is consumed. This results
in a range of unpleasant physiological reactions, including nausea, vomiting, headache, flushing,
palpitations, and dizziness. The goal of disulfiram therapy is to create a strong psychological
deterrent to drinking by associating alcohol consumption with highly discomforting effects. When
used as part of a comprehensive rehabilitation program, disulfiram can help reinforce abstinence
and support long-term recovery by discouraging relapse [49-52].
Naltrexone: An opioid antagonist that reduces alcohol cravings and the rewarding effects
of alcohol. An opioid antagonist is a pharmacological agent that works by blocking opioid
receptors in the brain, thereby reducing alcohol cravings and diminishing the pleasurable and
reinforcing effects of alcohol consumption. By interfering with the brain's reward system, this
medication helps individuals with alcohol dependence decrease their urge to drink and reduces the
likelihood of relapse. When incorporated into a comprehensive treatment program that includes
behavioral therapies and psychosocial support, opioid antagonists can significantly improve long-
term recovery outcomes [53-55].
Acamprosate: Helps restore neurotransmitter balance in the brain and supports abstinence.
This medication plays a crucial role in restoring the balance of neurotransmitters in the
brain, which is often disrupted by chronic alcohol use. By stabilizing brain chemistry, it helps
reduce withdrawal symptoms, alleviate cravings, and support long-term abstinence. When used as
part of a comprehensive treatment plan, it enhances recovery outcomes and improves overall
mental well-being. Baclofen and Gabapentin: Emerging treatments with potential efficacy in
reducing cravings and withdrawal symptoms. New and developing treatments show promising
potential in alleviating alcohol cravings and managing withdrawal symptoms. These emerging
therapies focus on targeting neurological and biochemical pathways involved in addiction, aiming
to improve recovery outcomes and reduce the risk of relapse [56-61].
5. Social Reintegration and Support Systems
Social support plays a crucial role in sustained recovery. Support groups such as Alcoholics
Anonymous (AA) and SMART Recovery provide peer support and accountability. Family therapy
and community-based programs help rebuild relationships and provide a stable environment for
recovery. Employment and vocational training programs also contribute to reintegration and self-
sufficiency.
6. Preventing Relapse
2025
FEBRUARY
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 2
314
Relapse prevention is a core component of rehabilitation. Strategies include: Preventing
relapse is a fundamental aspect of the rehabilitation process. Effective strategies involve a
combination of behavioral, psychological, and pharmacological interventions designed to help
individuals maintain sobriety and cope with triggers that may lead to relapse.
Identifying high-risk situations and developing coping mechanisms.
Engaging in regular therapy and support groups.
Maintaining a structured lifestyle with healthy activities.
Adhering to prescribed medication regimens.
7. Future Directions and Research
Despite advancements in treatment, alcoholism remains a challenging disorder to manage.
Future research should focus on personalized treatment approaches, novel
pharmacotherapies, and the integration of digital health tools (e.g., telemedicine, mobile apps) in
rehabilitation programs.
Conclusion:
The rehabilitation of alcoholism is a complex and multidimensional process
that necessitates a comprehensive approach involving medical, psychological, and social
interventions. Effective recovery is best achieved through a combination of detoxification,
evidence-based behavioral therapies, pharmacological treatments, and a robust support system.
Integrating these components enhances long-term sobriety, reduces the risk of relapse, and
promotes overall well-being. Furthermore, ongoing research and advancements in treatment
methodologies continue to refine rehabilitation strategies, increasing success rates and alleviating
the profound impact of alcoholism on individuals, families, and society as a whole.
REFERENCES
1.
Abdurashidovich N. O., Zamonbek o‘g‘li B. F., Temirpulotovich T. B. Assessment of the
relationship of the degree of conformity in patients with schizophrenia with clinical features
and socio-demographic factors //European journal of modern medicine and practice. – 2024.
– Т. 4. – №. 2. – С. 22-30.
2.
Akramov S., Buronov J., Turayev B. Clinical forms, course and treatment methods of
maniacal-depressive psychosis disease //Modern Science and Research. – 2025. – Т. 4. – №.
1. – С. 176-185.
3.
Antsiborov S. et al. Association of dopaminergic receptors of peripheral blood lymphocytes
with a risk of developing antipsychotic extrapyramidal diseases //Science and innovation. –
2023. – Т. 2. – №. D11. – С. 29-35.
2025
FEBRUARY
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 2
315
4.
Asanova R. et al. Features of the treatment of patients with mental disorders and
cardiovascular pathology //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 545-550.
5.
Begbudiyev M. et al. Integration of psychiatric care into primary care //Science and
innovation. – 2023. – Т. 2. – №. D12. – С. 551-557.
6.
Biktimirova G., Turayev B., Ochilova N. Features of the pathokinesis of adaptation disorders
in men with mild forms of cardiovascular disease //Modern Science and Research. – 2024.
– Т. 3. – №. 1. – С. 602-610.
7.
Bo’Riyev B. et al. Features of clinical and psychopathological examination of young
children //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 558-563.
8.
Borisova Y. et al. Concomitant mental disorders and social functioning of adults with high-
functioning autism/asperger syndrome //Science and innovation. – 2023. – Т. 2. – №. D11.
– С. 36-41.
9.
Buriboyevna A. D. et al. Hemorrhagic stroke-symptoms and treatment //Western European
Journal of Medicine and Medical Science. – 2024. – Т. 2. – №. 7. – С. 35-38.
10.
Djurabekova A. T. et al. Markaziy nerv sistemasining perinatal zararlanishi bilan tug’ilgan
bolalardagi ko’ruv analizatorining o’ziga xos klinik ko’rinishi //Uzbek journal of case
reports. – 2023. – Т. 3. – №. 3. – С. 77-79.
11.
Hamdullo o'g'li J. H., Temirpulotovich T. B. Features of the Clinical Course of Post-
Traumatic Epilepsy, Psychiatric and Neurosurgical Approaches //International Journal of
Cognitive Neuroscience and Psychology. – 2024. – Т. 2. – №. 2. – С. 8-14.
12.
Hamidullayevna X. D., Temirpulotovich T. B. Features of psycho-emotional changes in
women during pregnancy //Journal of Science in Medicine and Life. – 2024. – Т. 2. – №. 3.
– С. 71-77.
13.
Hamidullayevna X. D., Temirpulotovich T. B. Personality and interpersonal relationships of
primary school students with hyperactivity disorder of minimal brain dysfunction and
attention deficit //International Journal of Cognitive Neuroscience and Psychology. – 2024.
– Т. 2. – №. 3. – С. 22-27.
14.
Holdorovna I. M., Temirpulotovich T. B. Analysis of the psychopathological and
neurophysiological profile of children left without parental care //Journal of Science in
Medicine and Life. – 2024. – Т. 2. – №. 3. – С. 63-70.
15.
Holdorovna I. M., Temirpulotovich T. B. Psychopathological features of long-term
endogenous depressions //International Journal of Cognitive Neuroscience and Psychology.
– 2024. – Т. 2. – №. 3. – С. 15-21.
2025
FEBRUARY
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 2
316
16.
Ibragimova M., Turayev B., Shernazarov F. Features of the state of mind of students of
medical and non-medical specialties //Science and innovation. – 2023. – Т. 2. – №. D10. –
С. 179-183.
17.
Jalilova S. H., Kibriyev K., Turayev B. Contemporary accounts of schizophrenia //Modern
Science and Research. – 2025. – Т. 4. – №. 1.
18.
Kasimov A. A. et al. Dimensional Rhythmological Model of Depression //Central Asian
Journal of Medical and Natural Science. – 2023. – Т. 4. – №. 3. – С. 1133-1136.
19.
Kasimov A. A. et al. Methods of diagnosis early stage of parkinson's disease //World Bulletin
of Public Health. – 2023. – Т. 23. – С. 203-208.
20.
Kasimov A. A. et al. Therapeutic potential and prospects for the use of sermione
(nicergoline) inneurological practice causes //World Bulletin of Public Health. – 2023. – Т.
23. – С. 198-202.
21.
Khudoynazarovich M. N. et al. The basic principle of epilepsy treatment //Western European
Journal of Medicine and Medical Science. – 2024. – Т. 2. – №. 7. – С. 61-66.
22.
Konstantinova O. et al. Experience in the use of thiamine (vitamin B1) megadose in the
treatment of korsakov-type alcoholic encephalopathy //Science and innovation. – 2023. – Т.
2. – №. D12. – С. 564-570.
23.
Kosolapov V. et al. Modern strategies to help children and adolescents with anorexia nervosa
syndrome //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 571-575.
24.
Lomakin S. et al. Socio-demographic, personal and clinical characteristics of relatives of
patients with alcoholism //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 278-283.
25.
Mamurova M. M., Kelesh E. I., Abrorova V. Current views on discirculatory encephalopathy
in the background of hypotyreosis //Вестник магистратуры. – 2022. – №. 5-1 (128). – С.
12-14.
26.
Mamurova M. M., kizi Zhobborova R. S. Peculiarities in the development of chronic
cerebrovascular pathology with arterial hypotension in young patients //World Bulletin of
Public Health. – 2022. – Т. 9. – С. 168-170.
27.
Mavluda M. et al. Incidence Levels of Ischemic Heart Disease in Liver Cirrhosis //Research
Journal of Trauma and Disability Studies. – 2024. – Т. 3. – №. 4. – С. 239-240.
28.
Murodullayevich K. R., Holdorovna I. M., Temirpulotovich T. B. The effect of exogenous
factors on the clinical course of paranoid schizophrenia //Journal of healthcare and life-
science research. – 2023. – Т. 2. – №. 10. – С. 28-34.
2025
FEBRUARY
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 2
317
29.
Nematillayevna S. D. et al. Features of non-psychotic diseases and cognitive disorders in
organic brain damage of vascular genesis in elderly people //Amaliy va tibbiyot fanlari ilmiy
jurnali. – 2024. – Т. 3. – №. 2. – С. 124-130.
30.
Nematillayevna S. D. et al. Prevalence of anxiety and depressive disorders in elderly patients
//Scientific journal of applied and medical sciences. – 2024. – Т. 3. – №. 2. – С. 118-123.
31.
Novikov A. et al. Alcohol dependence and manifestation of autoagressive behavior in
patients of different types //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 413-419.
32.
Nurmamatovna A. Z. et al. Psychoemotional status in patients with atopic dermatitis
//Western European Journal of Medicine and Medical Science. – 2024. – Т. 2. – №. 7. – С.
46-49.
33.
Ochilov U. et al. Factors of alcoholic delirium patomorphosis //Science and innovation. –
2023. – Т. 2. – №. D12. – С. 223-229.
34.
Ochilov U. et al. The main forms of aggressive manifestations in the clinic of mental
disorders of children and adolescents and factors affecting their occurrence //Science and
innovation. – 2023. – Т. 2. – №. D11. – С. 42-48.
35.
Ochilov U. et al. The question of the features of clinical and immunological parameters in
the diagnosis of juvenile depression with" subpsychotic" symptoms //Science and
innovation. – 2023. – Т. 2. – №. D12. – С. 218-222.
36.
Olmosovna M. G. et al. Ischemic stroke symptoms and treatment //Western European
Journal of Medicine and Medical Science. – 2024. – Т. 2. – №. 7. – С. 67-72.
37.
Pachulia Y. et al. Assessment of the effect of psychopathic disorders on the dynamics of
withdrawal syndrome in synthetic cannabinoid addiction //Science and innovation. – 2023.
– Т. 2. – №. D12. – С. 240-244.
38.
Rotanov A. et al. Comparative effectiveness of treatment of somatoform diseases in
psychotherapeutic practice //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 267-
272.
39.
Rotanov A. et al. Social, socio-cultural and behavioral risk factors for the spread of hiv
infection //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 49-55.
40.
Rotanov A. et al. Suicide and epidemiology and risk factors in oncological diseases //Science
and innovation. – 2023. – Т. 2. – №. D12. – С. 398-403.
41.
Sadullayeva R., Sharafova M., Turayev B. The development of psychoses in infectious
diseases and their clinical features //Modern Science and Research. – 2025. – Т. 4. – №. 1.
– С. 124-129.
2025
FEBRUARY
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 2
318
42.
Sedenkov V. et al. Clinical and socio-demographic characteristics of elderly patients with
suicide attempts //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 273-277.
43.
Sultanov S. et al. Psychotherapeutic preparation for orthopedic treatment of dental patients
and adaptation to prosthetics //Modern Science and Research. – 2025. – Т. 4. – №. 1. – С.
290-296.
44.
Sultanov S. et al. Psychotherapeutic problems in the process of treatment in various areas of
medicine //Modern Science and Research. – 2025. – Т. 4. – №. 1. – С. 279-289.
45.
Temirpulotovich T. B. Clinical Course of Alcoholic Polyneuropathy and Alcoholic
Myopathy Observed in Alcoholism //Journal of Medical Genetics and Clinical Biology. –
2025. – Т. 2. – №. 3. – С. 34-41.
46.
Temirpulotovich T. B. Clinical Pictures of Cognitive Dysfunctions Observed in Alcoholism
//Journal of Medical Genetics and Clinical Biology. – 2025. – Т. 2. – №. 3. – С. 42-50.
47.
Tursunboyev M., Yaxyayev M., Turayev B. Clinical psychopathological features of sleep
disorders //Modern Science and Research. – 2025. – Т. 4. – №. 1. – С. 130-139.
48.
Xushvaktova D., Turayev B., Shernazarov F. Clinical features of mental disorders in
synthetic drug users //Science and innovation. – 2023. – Т. 2. – №. D10. – С. 242-247.
49.
Абсаламова З. и др. Воздействие мелатонина при болезни альцгеймера (литературный
обзор) //Евразийский журнал академических исследований. – 2023. – Т. 3. – №. 6 Part
3. – С. 178-188.
50.
Анваров У. и др. Нейровизуализационные и нейропсихологические исследования в
клинике черепно-мозговой травмы легкой и средней степени тяжести
//Центральноазиатский журнал образования и инноваций. – 2023. – Т. 2. – №. 6 Part 6.
– С. 190-205.
51.
Джуракулов Ж. и др. Результаты применения внутривенной озонотерапии у
пациентов с хронической ишемией головного мозга //Журнал проблемы биологии и
медицины. – 2017. – №. 2 (94). – С. 35-39.
52.
Зарипов Ж., Мамурова М. Ранняя диагностика болезни паркинсона и
прогнозировании трансформации эссенциального тремора //Current approaches and
new research in modern sciences. – 2024. – Т. 3. – №. 5. – С. 56-59.
53.
Зарипов С. и др. Нарушение функции митохондрий при нейродегенеративных
заболеваниях (литературный обзор) //Евразийский журнал академических
исследований. – 2023. – Т. 3. – №. 6 Part 3. – С. 169-177.
2025
FEBRUARY
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 2
319
54.
Касимов А. А. и др. Использование Ривастигмина При Деменциях: От
Симптоматического Эффекта К Нейропротекции //amaliy va tibbiyot fanlari ilmiy
jurnali. – 2023. – Т. 2. – №. 6. – С. 116-124.
55.
Киличов Ж. Г. и др. Сравнительная Эффективность Терапии Типичными И
Атипичными Антипсихотиками //Amaliy va tibbiyot fanlari ilmiy jurnali. – 2023. – Т. 2.
– №. 6. – С. 110-115.
56.
Мамурова М. и др. Современные методы диагностики болезни паркинсона на ранних
стадиях //Центральноазиатский журнал образования и инноваций. – 2023. – Т. 2. – №.
6 Part 6. – С. 180-189.
57.
Мамурова М. и др. Частота когнитивных и некогнитивных нарушений у пациентов
молодого возраста с хроническими цереброваскулярными заболеваниями
обусловлеными артериальной гипертензией //Журнал проблемы биологии и
медицины. – 2018. – №. 1 (99). – С. 63-66.
58.
Мустафоев А. И. И др. Катта қуёш қурилмасининг технологик имкониятлари
//Innovative Development in Educational Activities. – 2023. – Т. 2. – №. 5. – С. 428-435.
59.
Мустафоев А. И. И др. Маҳаллий хом-ашёларга асосланган 17000с ҳароратда
ишлайдиган термостатланган электр печи //Innovative Development in Educational
Activities. – 2023. – Т. 2. – №. 9. – С. 159-163.
60.
Рахманова Ф. Э., Холмуродова Д. К. Применение оксида азота для антимикробных,
ранозаживляющих кожных лечебных мазей //International scientific review of the
problems of natural sciences and medicine. – 2022. – С. 8-20.
61.
Рахмонова Ф. Э. Нейропротективные, гипотензивные, антигипоксические свойства
шпината //o'zbekistonda fanlararo innovatsiyalar va ilmiy tadqiqotlar jurnali. – 2025. – Т.
3. – №. 36. – С. 212-216.
